President Donald Trump’s Day One executive order rescinding Biden-era Medicare and Medicaid price innovation programs signals sweeping changes to the drug and treatment pricing agency within the Centers for Medicare and Medicaid Services and perhaps a substantive shake-up in two of the largest federal social welfare programs.

Donald Trump has rescinded an executive order from President Joe Biden that sought to lower the price of drugs.

Adam Colborn, JD, of AMCP, discussed how President Trump's rescission of several Biden-era executive orders may impact Medicaid and Medicare initiatives.

A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe Biden on lowering prescription drug costs in posts online that suggest President Donald Trump has canceled the $35 insulin co-pay cap for certain Medicare programs.

The order, widely expected to be challenged in court, could block recipients from being able to receive the treatments and have a chilling effect on providers willing to offer care.

Despite online claims, President Donald Trump’s executive orders did not include removing Medicare’s $35 monthly out-of-pocket price cap, which is set by law.

Trump stopped a program that had been in the works and was intended to give Medicare recipients access to more than 100 generic drugs for $2 a month, according to another executive order signed on Trump's first day in his new term.

Robert F. Kennedy Jr., nominee for HHS secretary, seemed unfamiliar with the massive insurance program during Thursday’s hearing, mistakenly saying Medicare Part A mainly paid for primary care or physicians.

President Donald Trump issued a flurry of executive orders during the first ... one of the orders revoked was one that lowered prescription drug costs for people on Medicare and Medicaid. Several VERIFY readers asked us if these posts are true.

If approved, Kennedy will control a $1.7 trillion agency that oversees food and hospital inspections, hundreds of health clinics, vaccine recommendations and health insurance for roughly half the country.

After two days of Senate committee hearings, four Republicans have declined to commit to approving Robert F. Kennedy Jr., whose stance on vaccines remains a hot-button issue even after being presented with scientific evidence.